1 / 24

THE CARDIOLOGY CONNECTION

THE CARDIOLOGY CONNECTION GUIDELINES FOR PREVENTION OF DISEASE PROGRESSION Peter K. Shaw, MD, FACC October 12, 2005 The Problem CAD -- leading cause of death and disability in U.S. among men and women Huge numbers: In 1997: AMI diagnosis in 1.1 million people

jaden
Télécharger la présentation

THE CARDIOLOGY CONNECTION

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. THE CARDIOLOGY CONNECTION GUIDELINES FOR PREVENTION OF DISEASE PROGRESSION Peter K. Shaw, MD, FACC October 12, 2005

  2. The Problem • CAD -- leading cause of death and disability in U.S. among men and women • Huge numbers: In 1997: • AMI diagnosis in 1.1 million people • > 0.8 million revascularization procedures • Prevention of subsequent events and enhancement of physical function in patients have immense impact

  3. Cardiac Rehabilitation • Before the mid-20th C., treatment of MI: • 3 weeks of bedrest • Out of work up to 6 months, if work was to be permitted • Little understanding about the pathophysiology, causes, appropriate treatment, and prevention of subsequent events • Chair therapy: a major and courageous breakthrough!

  4. Cardiac Rehabilitation-2 • Programs 1st developed in 1960s • Benefits of ambulation recognized • Safer in supervised environment than at home • Developed into highly structured, physician and nurse-supervised, ECG monitored programs • Focus primarily on exercise (as medicine) • Dosage • Frequency • Intensity

  5. Cardiac Rehabilitation-3 • Hospital stays for MI and ACS 3-5 days • Reduced deconditioning • However, reduced opportunity for patient education • Regular exercise and risk factor modification reduce morbidity and mortality of CHD • Cardiac Rehab: assessment and modification of risk factors--> Secondary-prevention centers

  6. Cardiac Rehabilitation-4 • Exercise after MI: reduced overall and cardiac causes of mortality • Decreased rates of subsequent coronary events and hospitalizations • More efficient and effective than individual physician care: most care providers: • not fully trained in cardiac rehab techniques • inadequate time for effective nutritional advice, weight mgmt, exercise prescription

  7. Cardiac Rehabilitation-5 • Appropriate subjects: • AMI • Coronary revascularization • Chronic stable angina pectoris • CHF • Post cardiac transplant • Goals: • Prevent disability • Prevent subsequent coronary events

  8. Exercise Training • Cardiac arrest: 1/112,000 patient-hours • Non-fatal MI: 1/294,000 patient-hours • Mortality: 1/784,000 patient-hours • Exercise capacity:(aerobic conditioning, 3x/wk, over 3 mo) • increase by 30-50% • peak O2 consumption inc. 15-20% • Subjective improvement in performance of ADLs (climbing stairs, carrying groceries) • Higher angina threshold due to lower HRxBPs product as a result of aerobic conditioning • Physiologic adaptations are both central (cardiac) and peripheral (skeletal muscle and vascular)

  9. The Bottom Line • Long-term mortality from CV and all causes (meta-analyses ‘70s-’80s) • Cardiac rehab w/ 25% reduction in overall and CV mortality over 3 years • Why? • Improved lipids • Improved coronary blood flow • Reduced obesity • Improved HR variability and autonomic tone • Increased fibrinolysis • Improvement in psychological factors • EXERCISE TRAINING IMPROVES FNL CAPACITY, REDUCES SXS IN PTS W/ CAD, & REDUCES OVERALL AND CV MORTALITY

  10. Cardiac Rehab in DM-2 • Ongoing drug therapy (insulin, oral hypoglycemic agents) and need for exercise-related dose adjustments • Techniques of self-monitoring have become essential to pursue effective and safe exercise rehabilitation • Complications (retinopathy, neuropathy, nephropathy) all affect exercise prescription • Higher prevalence of silent ischemia requires careful monitoring

  11. BENEFIT IN TYPE 2 DM • 59 DM2 pts (vs 36 age-matched non-DM controls) • 2 month program after acute coronary event • After program, improvement in exercise capacity lower in diabetic pts • In pts with DM, significant inverse relation btw FBS and change in peak VO2 • Thus, degree of glycemic control may have important implications in success of exercise rehabilitation in this cohort. • Verges, et al. Diabet Med. 2004 Aug:21 (8): 889-95

  12. RESULTS OF CARDIAC REHAB IN PTS WITH DM • In 2003 study, 26% of pts in a program at Boston Medical Ctr. had DM • 53% taking insulin &/or oral hypoglycemic medication • Greater risk profile, with higher prevalence of • hypertension -PVD • obesity -lower ex. Capacity • Initial Hgb A1C 8.4% • Fewer DM pts completed program (38% vs 48%) • exacerbation of medical problem (both cardiac and noncardiac) cause of dropout (29% vs. 18%) • Banzer et al., AmJCard 93 (1) 2004 Jan1 (81-84)

  13. APPROACH TO INVOLVEMENT OF DIABETIC PATIENT IN CARDIAC REHABILITATION • At intake appt, nurse card mgr reviews program guidelines with participant and involves PCP re: medication or diet adjustments before starting program • Classroom “Diabetes 101” review of diabetic guidelines for exercise • Participants encouraged to bring their own monitors (checked for accuracy by Program Monitor…+/- 20% acceptable accuracy) • BG monitored 15-30 min prior to exercise, and post-exercise for at least 3 sessions • If BG out of range, set protocol for intervention and consultation with PCP

  14. PROTOCOL

  15. TREATMENT OF HYPOGLYCEMIA • 50-100 mg/dl: 15 gm CHO; repeat BG testing after 15 minutes. May exercise when BG >120 mg/dl • <50 mg/dl: 30 gm CHO. Consider glucagon. Repeat BG testing after 15 minutes. Repeat CHO until BG >120 mg/dl and free of hypoglycemic sxs.

  16. VALUE OF CARDIAC REHABILITATION IN DM • The participant understands the importance of regular exercise as part of a comprehensive medical management strategy: “EXERCISE IS MEDICINE” • Establishes a habit and a rhythm of regular participation • Teaching safe methods of exercise • avoidance of pre- or post-exercise hypoglycemia • encourages choice of exercise appropriate to particular condition (neuropathy, retinopathy, nephropathy) • Encourages frequent testing as guide to safe approach • Participant understands diabetes as part of a collection of coronary risk factors--inspires patient to take responsibility for own medical condition

  17. Effects on Coronary Risk Factors • Lipids: 8-23% increase in HDL • Increase of chol/HDL = 5-26% • However, exercise training alone: • Minimal effect on LDL • 0-2% change in body wt at 3 months • -5% fat mass, +2% muscle mass • Improved glucose tolerance and less insulin resistance

  18. Exercise Prescription • Consider risk factors, age, functional status • Moderate to high intensity, 3-5x/wk, 25-45 min per session • Low caloric expenditure: 270-283 kcal/session, not likely to induce wt loss without dietary changes • Regimen of low-intensity, prolonged daily exercise (“high caloric training”) leads to greater fat loss than more intense briefer sessions • Important to include resistance training to minimize loss of muscle mass • Intervals of relatively intense exercise may lead to improvement in endothelium-dependent coronary vasodilation after 4 wks.

  19. Summary of Components and Goals • Initial history and physical examination • Control hypertension • Smoking cessation • Weight loss if BMI > 25 • DM control • Psychosocial adjustments • Physical activity counseling and exercise prescription and training • Enhance compliance: • Exercise: 50% at one year --anti-htn meds: 64% • lipid-lowering meds: 82% --f/u necessary after program

  20. Comprehensive Risk Reduction • Smoking: decision to stop is central • Unequivocal message from health professionals • Pick a date --Involve important others • Behavioral skills for coping with stress, possible use of bupropion &/or nicotine supplements • Followup • Hyperlipoproteinemia • Diet --Medications --Exercise --Followup

  21. Comprehensive Risk Reduction-2 • Weight-loss • May lead to 4-9% reduction when exercise w/ dietary intervention • Improved lipid levels, insulin resistance, BP, clotting abnormalities • Stimulus control (behavioral changes) • Self-monitoring • Social support (non-judgmental) • Daily calorie count and recording • 5-10% reduction in bw may be sufficient to improve lipids and insulin resistance

  22. Comprehensive Risk Reduction-3 • BP and DM-2 benefited by exercise training, weight loss, and improved diet • Self-monitoring of BP and DM important skills to learn; will help PCP management • Psychological Factors: • Cardiac rehab improves measures of • anxiety + emotional stress +self-confidence • depression +social isolation +quality-of-life

  23. Challenges • Extension of services to indigent and uninsured • Geographic issues, especially in rural states • Reaching appropriate patients: • In hospital screening and recruitment • Prioritize communication and involvement of cardiologist and PCP for referral and close followup • Individualize programs • to be appropriate for elderly, younger patients, the physically challenged, and the remotely situated • risk-factor modifications appropriate for each case • emphasize the payoff: physical, behavioral, and risk-factor changes that will lead to improved outcomes

  24. Helpful Resources • Philip A. Ades, MD, Cardiac Rehabilitation and Secondary Prevention of Coronary Heart Disease NEJM 2001; 345:892-902. • Wenger, NK et al, Cardiac rehabilitation: clinical practice guidelines, 1995 (AHCPR publication no. 96-0672) • DeBusk, RF, et alCase-mgmt system for coronary risk-factor modification after AMI Ann Int Med 1994: 120: 721-729 • Linden W, et alPsychosocial interv for pts w cad: meta-analysis Arch Int Med 1996; 156: 745-752

More Related